Comparison of three generic vancomycin products using liquid chromatography-mass spectrometry and an online tool

American Journal of Health-System Pharmacy

Volumn 71, Issue 12, 2014, Pages 1029-1038

  Lewis, Paul O ^a   Kirk, Loren M ^c   Brown, Stacy D ^b  

^a Johnson City Medical Center   (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MANUFACTURE; ION MONITORING; LIQUID CHROMATOGRAPHY; METABOLOMICS; ONLINE SYSTEM; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REFERENCE VALUE; TANDEM MASS SPECTROMETRY; CHEMISTRY; DRUG STABILITY; DRUG STORAGE; FREEZING; MASS SPECTROMETRY; PROCEDURES; TIME;

ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, LIQUID; DRUG STABILITY; DRUG STORAGE; DRUGS, GENERIC; MASS SPECTROMETRY; ONLINE SYSTEMS; REFRIGERATION; TIME FACTORS; VANCOMYCIN;

EID: 84907222980     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp130516     Document Type: Article

References (21)

1. Griffith RS. Introduction to vancomycin. Rev Infect Dis. 1981; 3(suppl):S200-4.
2. Rybak M, Lomaestro B, Rotschafer JC et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm. 2009; 66:82-98.
3. Harris CM, Kopecka H, Harris TM. Vancomycin: structure and transformation to CDP-I. J Am Chem Soc. 1983; 105:6915-22.
4. Somerville AL, Wright DH, Rotschafer JC. Implications of vancomycin degradation products on therapeutic drug monitoring in patients with end-stage renal disease. Pharmacotherapy. 1999; 19:702-7.
5. Hadwiger ME, Sommers CD, Mans DJ et al. Quality assessment of U.S. marketplace vancomycin for injection products using high-resolution liquid chromatography-mass spectrometry and potency assays. Antimicrob Agents Chemother. 2012; 56:2824-30.
6. Smith CA, Want EJ, O'Maille G et al. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006; 78:779-87.
7. Tautenhahn R, Böttcher C, Neumann S. Highly sensitive feature detection for high resolution LC/MS. BMC Bioinformatics. 2008; 9:504.
8. Benton HP, Wong DM, Trauger SA et al. XCMS2: processing tandem mass spectrometry data for metabolite identification and structural characterization. Anal Chem. 2008; 80:6382-9.
9. Patti GJ, Tautenhahn R, Rinehart D et al. A view from above: the cloud plot for visualizing global metabolomic data. Anal Chem. 2013; 85:798-804.
10. Tautenhahn R, Patti GJ, Rinehart D et al. XCMS Online: a web-based platform to process untargeted metabolomic data. Anal Chem. 2012; 84:5035-9.
11. Tautenhahn R, Patti GJ, Kalisiak E et al. MetaXCMS: second-order analysis of untargeted metabolomics data. Anal Chem. 2011; 83:696-700.
12. Patti GJ, Yanes O, Siuzdak G. Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Bio. 2012; 13:263-9.
13. Frezza C, Zheng L, Tennant DA et al. Metabolic profiling of hypoxic cells revealed a catabolic signature required for cell survival. PLoS One. 2011; 6:e24411.
14. Patti GJ, Tautenhahn R, Siuzdak G. Meta-analysis of untargeted metabolomic data from multiple profiling experiments. Nat Protoc. 2012; 7:508-16.
15. Ishikawa T, Takahara K, Hirabayashi T et al. Metabolome analysis of response to oxidative stress in rice suspension cells overexpressing cell death suppressor Bax inhibitor-1. Plant Cell Physiol. 2010; 51:9-20.
16. Zhang A, Wang P, Sun H et al. High-throughput ultra-performance liquid chromatography-mass spectrometry characterization of metabolites guided by a bioinformatics program. Mol BioSyst. 2013; 9:2259-65.
17. Nambiar S, Madurawe RD, Zuk SM et al. Product quality of parenteral vancomycin products in the United States. Antimicrob Agent Chemother. 2012; 56:2819-23.
18. O'Donnell PB, Bokser AD. Remington: the science and practice of pharmacy, 21st ed. Philadelphia: Lippincott Williams & Wilkins; 2006:1025-6.
19. Vesga O, Agudelo M, Salazar BE et al. Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator. Antimicrob Agents Chemother. 2010; 54:3271-9.
20. Jones RN, Watters AA, Flamm RK et al. Comparative potencies of contemporary generic vancomycin lot: in vitro assay results from nine products and a reference reagent-grade sample. Diagn Microbiol Infect Dis. 2013; 76:237-8.
21. Tattevin P, Saleh-Mghir A, Davido B et al. Comparison of six generic vancomycin products for treatment of methicillin-resistant Staphylococcus aureus experimental endocarditis in rabbits. Antimicrob Agents Chemother. 2013; 57:1157-62.